These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14610384)

  • 1. Are statins indicated for the primary prevention of CAD in octogenarians? antagonist viewpoint.
    Foody JM; Krumholz HM
    Am J Geriatr Cardiol; 2003; 12(6):357-60. PubMed ID: 14610384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are statins indicated for the primary prevention of coronary heart disease in octogenarians? protagonist viewpoint.
    Stone NJ
    Am J Geriatr Cardiol; 2003; 12(6):351-6. PubMed ID: 14610383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials.
    Alsheikh-Ali AA; Karas RH
    Curr Atheroscler Rep; 2009 Mar; 11(2):100-4. PubMed ID: 19228482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of statin treatment on diabetic patients.
    Koshiyama H
    Curr Opin Investig Drugs; 2003 Apr; 4(4):395-400. PubMed ID: 12808877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statins and muscular side-effects].
    Brosteaux C; Ruiz J; Buclin T; Kuntzer T; Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):510, 512-4, 516-7. PubMed ID: 20373698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
    Ridker PM; Rifai N; Clearfield M; Downs JR; Weis SE; Miles JS; Gotto AM;
    N Engl J Med; 2001 Jun; 344(26):1959-65. PubMed ID: 11430324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of coronary heart disease with statins. Which patients profit?].
    Adam O; Forth W
    MMW Fortschr Med; 2003 Jun; 145(25):37-40. PubMed ID: 12891851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 12. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing clinical trials of statins.
    Gotto AM
    Am J Cardiol; 2001 Aug; 88(4A):36F-40F. PubMed ID: 11520486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering drug therapy in elderly patients.
    Berthold HK; Gouni-Berthold I
    Curr Pharm Des; 2011; 17(9):877-93. PubMed ID: 21418034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension management.
    Haq IU; Wallis EJ; Jackson PR; Yeo WW; Ramsay LE
    J Hypertens; 1999 Nov; 17(11):1641-6. PubMed ID: 10608479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in acute coronary syndromes.
    Reinhardt SC; Vaughan CJ
    Drugs Today (Barc); 2002 May; 38(5):339-50. PubMed ID: 12532169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study.
    Lemaitre RN; Psaty BM; Heckbert SR; Kronmal RA; Newman AB; Burke GL
    Arch Intern Med; 2002 Jun; 162(12):1395-400. PubMed ID: 12076239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.